The federal 340B Drug Pricing Program faces a potential transformation from discount models to rebate systems, creating unprecedented challenges for healthcare providers and manufacturers. Access expert guidance with Model N’s on-demand webinar to equip your organization with the strategies and tools needed to master the evolving 340B landscape.
Prepare for the Future of 340B Management
The debate around shifting the 340B program from a discount to a rebate model introduces considerable uncertainty. While manufacturers see benefits in validation and financial control, providers anticipate higher costs and resource strain. Regardless of the outcome, this potential change requires a robust strategy to manage complex implications. Model N offers an adaptable platform and expert guidance to ensure your organization is prepared for any scenario, maintaining compliance and operational efficiency.
In this on-demand webinar, we will:
Offered Free by: Model N
See All Resources from: Model N